|
|
 |
|
Viewing report
|
|
 |
 |
Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis, Rating and Ranking - A Worldwide Study
ADIS, Jan 2001, Pages: 247
The objective of this special client report is to identify 25+ innovative drugs in autoimmune and inflammatory disease therapeutics which are available for partnering, licensing and/or co-marketing.
The entire realm of autoimmune and inflammatory disease therapeutics is considered, segmented, evaluated and forecast as a backdrop for this opportunity analysis.
This special report provides an in-depth assessment of those programs which represent potential breakthrough therapies.
Customers who bought this item also bought
CNS Drug Licensing: Opportunities, Analysis, Rating and Ranking - A Worldwide Study
Antiviral Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study
Antibacterial Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study
Antibacterial: Drug Licensing Opportunities, 2002
The Worldwide Prescription Drug Market 2004
Cardiology Drug Licensing Opportunities, 2002
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
Worldwide Drug Discovery R&D
|
 |
|
|